LAURUSLABS - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.7
| Stock Code | LAURUSLABS | Market Cap | 74,608 Cr. | Current Price | 1,382 ₹ | High / Low | 1,392 ₹ |
| Stock P/E | 101 | Book Value | 97.3 ₹ | Dividend Yield | 0.14 % | ROCE | 15.9 % |
| ROE | 15.1 % | Face Value | 2.00 ₹ | DMA 50 | 1,186 ₹ | DMA 200 | 1,008 ₹ |
| Chg in FII Hold | -0.70 % | Chg in DII Hold | 1.54 % | PAT Qtr | 192 Cr. | PAT Prev Qtr | 175 Cr. |
| RSI | 80.7 | MACD | 69.2 | Volume | 13,42,845 | Avg Vol 1Wk | 17,61,205 |
| Low price | 604 ₹ | High price | 1,392 ₹ | PEG Ratio | -113 | Debt to equity | 0.40 |
| 52w Index | 98.8 % | Qtr Profit Var | -23.9 % | EPS | 13.7 ₹ | Industry PE | 31.6 |
📊 Analysis:
Laurus Labs is trading near its 52-week high (₹1,392) with RSI at 80.7, indicating an overbought zone. MACD at 69.2 confirms strong bullish momentum, but valuations are stretched with a P/E of 101 vs industry average of 31.6. Volume (13.4 lakh) is slightly below the weekly average, suggesting momentum may not sustain without fresh buying. This setup favors short-term intraday trades with strict discipline.
💡 Optimal Buy Zone:
₹1,375–₹1,380 if price sustains above VWAP and intraday support.
🎯 Exit Levels:
- Profit-taking: ₹1,395–₹1,400 (near resistance/high zone).
- Stop-loss: ₹1,365–₹1,368 (below intraday support).
⏱️ Intraday Exit Strategy:
If already holding, consider exiting when
- RSI dips below 78 intraday.
- Volume falls below 10 lakh with stagnating price action.
- Price fails to hold above ₹1,375 support.
---
### ✅ Positive
- PAT improved sequentially (₹175 Cr. → ₹192 Cr.).
- RSI and MACD confirm strong bullish momentum.
- DII holdings increased (+1.54%).
- ROE (15.1%) and ROCE (15.9%) show efficiency.
### ⚠️ Limitation
- Extremely high valuation (P/E 101 vs industry 31.6).
- PEG ratio negative (-113), poor valuation-to-growth alignment.
- RSI at 80.7 indicates overbought zone, risk of pullback.
- FII holdings declined (-0.70%).
### 📉 Company Negative News
- Quarterly profit variation shows -23.9% decline.
- Elevated debt-to-equity ratio (0.40).
### 📈 Company Positive News
- Stock trading near 52-week high (₹1,392).
- Breakout above DMA 50 (₹1,186) and DMA 200 (₹1,008).
- EPS at ₹13.7 reflects earnings strength.
### 🏭 Industry
- Pharma sector average P/E at 31.6, Laurus Labs trades at a steep premium.
- Sector supported by long-term healthcare demand, though valuations are moderating.
### 📌 Conclusion
Laurus Labs is a momentum-driven intraday candidate with limited upside near its 52-week high. Suitable for quick trades with strict stop-loss discipline. Avoid chasing above ₹1,392 unless volume breakout confirms; best entries are near ₹1,375 with exits around ₹1,395–₹1,400.
This analysis frames Laurus Labs as a short-term momentum trade rather than a fundamentally strong candidate. Would you like me to extend this into a medium-term swing trade setup with entry/exit zones based on DMA and sector overlays?